Volunteer in our research studies

Dry Eyes

Study Title This study may be a good fit for you if you meet the following criteria

Changes in corneal epithelial irregularity following treatment with artificial tears in a symptomatic dry eye population

  • Are aged 18 years or older with symptoms of dry eye within the past 6 months
  • Have not worn contact lenses for 1 month prior to the study and for the duration of the study
  • Are willing to use the study eye drops and refrain from using any other eye drops for the duration of the study
  • Willing to refrain from using warm compress treatments for dry eye for the duration of the trial
  • Have not had significant changes to prescription medications or diet implemented within 3 months prior to the first visit nor planned changes for the duration of the trial
  • Are not pregnant or breastfeeding
  • Do not have any known allergy to the study eye drops
  • Have not had any eye surgery

The effect of eyelid wipes with Manuka Honey on Ocular Signs and Symptoms

  • Adult aged 18 years or older
  • Able to read and comprehend English
  • Have symptoms of dry eye
  • At least 1 sign of dry eye
  • Willing to not change any current dry eye treatment regimen

Efficacy of Eye Masks + Manuka Honey eyedrops on Dry Eyes

  • Are aged 18 years or older with symptoms of dry eye
  • Have not used Optimel Manuka+ Dry Eye Drops in the past 3 months
  • Have not used warm compresses or lid scrubs in the past 1 month
  • Willing to discontinue current use of any other rewetting/lubricating drops 3 days before the study and throughout the study
  • Are a soft contact lens wearer: willing to discontinue lens wear for 1 week before first visit and continue to do so until the conclusion of the study (approx. 1 month duration)
  • Are a rigid contact lens wearer: willing to discontinue lens wear for 1 month prior to the study and during the study.
  • Willing to discontinue use of any previous dry eye treatment methods used before and throughout the study

A Multicenter, Vehicle-controlled, Randomized Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Patients with Meibomian Gland Dysfunction (MGD)

  • Adult aged 18 years or over
  • Signs and symptoms of dry eye within the last 3 months
  • Wiling to discontinue other treatments for dry eye and MGD for at least 2 weeks prior to the first visit and for the duration of the study  
  • Willing to provide written informed consent and likely to complete the entire course of study according to instructions
  • Not pregnant or breastfeeding

The role of the microbiome in dry eye

  • Are aged over 18 years
  • Have not worn contact lenses in the past 3 months
  • [Meibomian gland dysfunction group] Have been diagnosed with mild to moderate meibomian gland dysfunction, either with or without lacrimal gland dysfunction
  • [Healthy group] Do not have meibomian gland dysfunction or dry eye
  • Have not had any eye trauma or eye surgery (including previous cataract or corneal refractive surgery)
  • Must not be using any systematic or topical antibiotic, anti-inflammatory, immunosuppressive medication, over the counter drops containing preservatives and also topical galucoma medication in the past 3 months